Shanghai Sanyou Medical Co., Ltd (688085.SS) has a MoatMap StockRank of 18/100 based on Quality (59/100), Value (20/100), and Momentum (24/100) factor scores. The current signal is STRONG SELL. Shanghai Sanyou Medical manufactures orthopedic implants. While healthcare has structural demand, the company is highly vulnerable to China's volume-based procurement (VBP) policies, which strip away pricing power and compress margins, violating the Terry Smith lens.
Shanghai Sanyou Medical Co., Ltd. designs, manufactures, and sells orthopedic implants, primarily focusing on spinal and trauma fixation systems. The company has a strong R&D pipeline with proprietary designs tailored to Asian anatomical structures, supported by a robust domestic clinical network. It is a leading domestic medical device company benefiting from China's volume-based procurement (VBP) policies driving import substitution.
| Price | $1.81 |
| Market Cap | $755M |
| P/E (TTM) | 83.41 |
| Price/Book | 2.23 |
| Return on Equity | 1.7% |
| Return on Invested Capital | 2.6% |
| Debt/Equity | 1.76 |
| Gross Margin | 71.1% |
| Operating Margin | 5.8% |
| Revenue Growth | 6.1% |
| Dividend Yield | 0.0% |
| Free Cash Flow | $-456K |
Shanghai Sanyou Medical Co., Ltd operates in the Medical Devices industry, part of the Healthcare sector (China).